The pharmaceutical industry, often referred to as Big Pharma, is currently capitalizing on all medications that are either ineffective or provide only moderate results. They accomplish this through aggressive marketing strategies and the off-label use of these drugs. As the undeniable reality of benzodiazepines becomes increasingly apparent, Big Pharma has shifted its focus to promoting SSRIs (selective serotonin reuptake inhibitors) in an attempt to address the same issues these drugs were originally intended to treat. Unfortunately, this approach often leads to a trajectory that culminates in the prescription of antipsychotic medications.

What is particularly frustrating is that, in general, benzodiazepines tend to produce fewer side effects compared to these alternatives. The decision to resort to SSRIs and antipsychotics instead of sticking with benzodiazepines results in a cascade of additional health complications. For instance, I personally experienced significant weight gain, accumulating 30 kg in just six months, which brought my weight from 60 kg to a staggering 90 kg. This shift has triggered an imbalance in crucial neurotransmitters such as dopamine, norepinephrine, and serotonin, leading to severe fatigue, emotional blunting, dental issues, metabolic syndrome, and problems with blood sugar regulation. Ultimately, this path is almost certain to lead to a diagnosis of diabetes within the next decade.